SEI Investments’s Tango Therapeutics TNGX Stock Holding History

SEI Investments’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	50,039 +18,077	+57%	+$447K	﹤0.01%	2076
2026 Q1	$669K	Sell	31,962 -21,965	-41%	-$306K	﹤0.01%	2551
2025 Q4	$478K	Buy	53,927 +43,882	+437%	+$378K	﹤0.01%	2523
2025 Q3	$84.4K	Buy	+10,045	New	+$68K	﹤0.01%	2737
2025 Q2	–	Sell	-57,086	Closed	-$78.2K	–	2907
2025 Q1	$78.2K	Buy	+57,086	New	+$140K	﹤0.01%	2641
2023 Q4	–	Sell	-35,020	Closed	-$394K	–	2677
2023 Q3	$394K	Buy	+35,020	New	+$214K	﹤0.01%	2204

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SEI Investments's TNGX Position: Q2 2026 in Review

SEI Investments increased its Tango Therapeutics (TNGX) stake by 57% in Q2 2026, buying an estimated $447K and bringing the position to 50,039 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

SEI Investments first reported a position in TNGX in Q3 2023 and has held it in 6 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

SEI Investments held 50,039 shares of Tango Therapeutics worth $1.56M as of Q2 2026.
SEI Investments bought 18,077 Tango Therapeutics shares in Q2 2026, an estimated $447K.
Tango Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2076 holding.
SEI Investments first reported a position in Tango Therapeutics in Q3 2023 and has held it in 6 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.